Meta-genomic next-generation sequencing in the diagnosis of brucellosis: Five cases from a non-endemic area
Authors:
- 7 August 2024
- journal article
- Published by Taylor & Francis in Future Microbiology
- Vol. 19 (13) , 1111-1117
Abstract
No abstract availableFunding Information
- National Key R&D Program of China (2022YFC2304500, 2022 YFC2304505)
- Zhejiang Province Natural Science Foundation (LY23H200001)
This publication has 27 references indexed in Scilit:
- Study on the value of second‐generation sequencing technology in the clinical diagnosis of osteoarticular brucellosisJournal of Orthopaedic Research, 2024
- Long ignored but making a comeback: a worldwide epidemiological evolution of human brucellosisEmerging Microbes & Infections, 2024
- Brucellosis: epidemiology, pathogenesis, diagnosis and treatment–a comprehensive reviewAnnals of Medicine, 2023
- Clinical usefulness of metagenomic next-generation sequencing for Rickettsia and Coxiella burnetii diagnosisEuropean Journal of Clinical Microbiology & Infectious Diseases, 2023
- BrucellosisJournal of the Neurological Sciences, 2021
- Epidemiological trends of notified human brucellosis in Germany, 2006–2018International Journal of Infectious Diseases, 2020
- Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical PracticeClinical Infectious Diseases, 2018
- Understanding the Promises and Hurdles of Metagenomic Next-Generation Sequencing as a Diagnostic Tool for Infectious DiseasesClinical Infectious Diseases, 2017
- The new global map of human brucellosisThe Lancet Infectious Diseases, 2006
- BrucellosisNew England Journal of Medicine, 2005